Gene Therapy Weekly: AI, CRISPR & Rare Disease Trials Heating Up | GENEration Hope
Update for the week of June 17, 2026
This week in genetic medicine: AI is learning to think like a neurologist, rare disease families are seeing first patients dosed in long-awaited trials, and CRISPR just unlocked a new way to destroy cancer cells once thought untreatable. If you're navigating the rare disease world — or just watching closely — this one's worth your time.
*In this week's update:*
[0:00] Welcome + 10,000 subscriber milestone 🎉
[1:10] Verge Labs unveils vBx — a foundation AI model built for precision neurology
[2:25] Kleefstra Syndrome Foundation partners with Unravel Biosciences for AI-powered drug repurposing
[3:40] ConSynance Therapeutics doses first patient in Phase 2a trial for Prader-Willi Syndrome
[4:50] Rafael Holdings completes last patient visit in pivotal Phase 3 Niemann-Pick Disease Type C trial — NDA filing ahead
[6:00] New CRISPR technique selectively destroys "undruggable" cancer cells
[7:15] Closing thoughts
Progress isn't just a word. It's families getting closer to answers. Every week, GENEration Hope tracks the science, the trials, and the human stories behind them — so you don't have to do it alone.
*GENEration Hope* is a documentary and media platform covering rare genetic disorders, gene therapy, and the families navigating this world. Created by Ron Kleiman, a filmmaker and rare disease dad whose daughter Evie has Phelan-McDermid Syndrome.
🔔 Subscribe and hit the bell for weekly genetic medicine updates.
🌐 *Links:*
Newsletter + more: [GENERATIONHOPE.CO]
YouTube Channel: [@GENErationHope_1]
📰 *Sources:*
Verge Labs / vBx: https://www.prnewswire.com/news-relea...
IDefine / Unravel Biosciences: https://www.idefine.org/cso-corner-vo...
ConSynance / Prader-Willi: https://www.globenewswire.com/news-re...
Rafael Holdings / Niemann-Pick: [SOURCE URL]
IGI / CRISPR Cancer: https://innovativegenomics.org/news/c...
---
```
0:00 Welcome + 10K Subscribers
1:10 Verge Labs vBx: AI for Precision Neurology
2:25 Kleefstra Syndrome + AI Drug Repurposing
3:40 First Patient Dosed: Prader-Willi Phase 2a Trial
4:50 Niemann-Pick Disease: Phase 3 Complete, NDA Ahead
6:00 CRISPR Destroys "Undruggable" Cancer Cells
7:15 Closing Thoughts
```